使用肝胆特异性MR对比剂时腹膜和胸腔积液在肝胆期可呈高信号
研究纳入两个中心139例无胆漏的腹膜或胸腔积液患者,在1.5T和3T下使用Gd-BOPTA或Gd-EOB-DTPA行肝胆期MRI,描述对比剂对积液信号的影响。结果显示Gd-BOPTA注射后肝胆期腹膜积液88-100%呈高或等信号、胸腔积液100%呈高或等信号,而Gd-EOB-DTPA注射后所有积液均保持低信号;两种对比剂后积液信号均随时间增加,但Gd-BOPTA的相对信号增强显著更高。
要点
- Gd-BOPTA注射后肝胆期腹膜积液88-100%呈高或等信号,胸腔积液100%呈高或等信号。
- Gd-EOB-DTPA注射后肝胆期所有腹膜和胸腔积液均保持低信号。
- 积液相对信号增强随肝胆期采集时间点延长而增加,且Gd-BOPTA后高于Gd-EOB-DTPA后。
核心结论
- 无胆漏时,腹膜和胸腔积液的信号强度在肝胆特异性对比剂注射后逐渐增加,Gd-BOPTA因肝胆期较晚而更明显,导致积液呈高信号,而Gd-EOB-DTPA注射后未观察到此现象。
研究设计与样本
- 研究纳入2015年10月至2016年5月两个中心的139例无胆漏的腹膜或胸腔积液患者(平均60±10岁,69%为男性),在1.5T和3T下使用Gd-BOPTA或Gd-EOB-DTPA行肝胆期MRI,将积液信号分为低/等/高信号并计算相对信号增强。
关键影像表现/征象
- Gd-BOPTA注射后肝胆期腹膜积液88-100%呈高或等信号,胸腔积液100%呈高或等信号。
- Gd-EOB-DTPA注射后肝胆期所有腹膜和胸腔积液均保持低信号。
- 两种对比剂后积液信号均增加,但Gd-BOPTA的相对信号增强显著更高(p=0.002至<0.001)。
- 相对信号增强与肝胆期采集时间点相关(腹膜积液r=0.42,p<0.001;胸腔积液r=0.50,p=0.033)。
- 慢性肝病患者的积液相对信号增强更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To describe the effect of hepatobiliary-specific MR imaging contrast agent (HBCA) administration on the signal intensity of peritoneal and pleural fluid effusions on T1-weighted MR images.
MATERIALS AND METHODS: From October 2015 to May 2016 139 patients (mean 60±10 years old, 69 % males) with peritoneal or pleural effusions without biliary leakage who underwent HBCA-MRI (Gd-BOPTA or Gd-EOB-DTPA) at 1.5T and 3T were included from two centres. The fluid signal intensity was classified as hypo/iso/hyperintense before/after HBCA administration. The relative signal enhancement (RE) was calculated.
RESULTS: On hepatobiliary phase (HBP), peritoneal fluids appeared hyper/isointense in 88-100 % and pleural effusions in 100 % of the patients following Gd-BOPTA administration. All fluids remained hypointense following Gd-EOB-DTPA. The signal intensity of fluids increased with both HBCA but RE was significantly higher following Gd-BOPTA (p=0.002 to <0.001). RE was correlated with HBP acquisition time-point (r=0.42, p<0.001 and r=0.50, p=0.033 for peritoneal and pleural fluids).
CONCLUSION: The signal intensity of pleural and peritoneal fluids progressively increases following HBCA administration in the absence of biliary leakage. Due to its later hepatobiliary phase, this is more pronounced after Gd-BOPTA injection, leading to fluid hyperintensity that is not observed after Gd-EOB-DTPA injection.
KEY POINTS: • Fluids appear hyper/isointense on HBP in most patients after Gd-BOPTA injection. • Fluids remain hypointense on HBP after Gd-EOB-DTPA injection. • RE of fluids increases with time after liver-specific Gd injection. • RE of fluids is higher in patients with chronic liver disease.
引用
- Ciolina M, Di Martino M, Bruno O, et al. Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents. Eur Radiol. 2018. PMID: 29374320. doi:10.1007/s00330-017-5261-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。